Shire, Roche in court fight Pharmaceutical group Shire has obtained a preliminary injunction in a Hamburg court against rival Roche over its haemophilia drug emicizumab, alleging incomplete and misleading statements surrounding the treatment. Roche is hoping to win a slice of the US$11bn/year haemophilia drug market with the drug, also known as ACE910, which has been designed to compete with more traditional treatments from Novo Nordisk and Shire — Reuters Carillion misses profit goal Carillion’s stock price plunged the most on record after the British construction company said first-half profit will be lower than expected, dividend payments will be suspended and CEO Richard Howson has stepped down. Cash flow from some projects has deteriorated, and the board will review all its major contracts with the help of KPMG, Carillion said in a statement. The company will also undertake a "comprehensive review" of the business and capital structure, with all options to boost the stock price...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.